"Drug Carriers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers.
| Descriptor ID |
D004337
|
| MeSH Number(s) |
D26.255.260 E02.319.300.380
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Drug Carriers".
Below are MeSH descriptors whose meaning is more specific than "Drug Carriers".
This graph shows the total number of publications written about "Drug Carriers" by people in this website by year, and whether "Drug Carriers" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 2 | 1 | 3 |
| 2006 | 2 | 1 | 3 |
| 2007 | 1 | 0 | 1 |
| 2008 | 2 | 5 | 7 |
| 2009 | 3 | 1 | 4 |
| 2010 | 4 | 3 | 7 |
| 2011 | 6 | 0 | 6 |
| 2012 | 2 | 3 | 5 |
| 2013 | 6 | 4 | 10 |
| 2014 | 3 | 4 | 7 |
| 2015 | 5 | 0 | 5 |
| 2016 | 6 | 5 | 11 |
| 2017 | 4 | 2 | 6 |
| 2018 | 3 | 1 | 4 |
| 2019 | 1 | 1 | 2 |
| 2020 | 3 | 3 | 6 |
| 2021 | 1 | 1 | 2 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Carriers" by people in Profiles.
-
Kaur G, Khanna B, Yusuf M, Sharma A, Khajuria A, Alajangi HK, Jaiswal PK, Sachdeva M, Barnwal RP, Singh G. A Path of Novelty from Nanoparticles to Nanobots: Theragnostic Approach for Targeting Cancer Therapy. Crit Rev Ther Drug Carrier Syst. 2024; 41(4):1-38.
-
Esquivel SV, Bhatt HN, Diwan R, Habib A, Lee WY, Khatun Z, Nurunnabi M. ?-Glucan and Fatty Acid Based Mucoadhesive Carrier for Gastrointestinal Tract Specific Local and Sustained Drug Delivery. Biomolecules. 2023 04 28; 13(5).
-
Kumar R, Islam T, Nurunnabi M. Mucoadhesive carriers for oral drug delivery. J Control Release. 2022 11; 351:504-559.
-
McCarthy PC, Zhang Y, Abebe F. Recent Applications of Dual-Stimuli Responsive Chitosan Hydrogel Nanocomposites as Drug Delivery Tools. Molecules. 2021 Aug 05; 26(16).
-
Dahiya S, Dahiya R, Hern?ndez E. Nanocarriers for Anticancer Drug Targeting: Recent Trends and Challenges. Crit Rev Ther Drug Carrier Syst. 2021; 38(6):49-103.
-
Li J, Canseco D, Wang Y, Vale G, Chaudhary J, Anwar A, Baniasadi H, Williams NS, Gopal P, Sutphin PD, McDonald JG, Putnam WC, Corbin IR. Assessing the safety of transarterial locoregional delivery of low-density lipoprotein docosahexaenoic acid nanoparticles to the rat liver. Eur J Pharm Biopharm. 2021 Jan; 158:273-283.
-
Shrestha B, Wang L, Zhang H, Hung CY, Tang L. Gold Nanoparticles Mediated Drug-Gene Combinational Therapy for Breast Cancer Treatment. Int J Nanomedicine. 2020; 15:8109-8119.
-
Hanley TM, Vankayala R, Mac JT, Lo DD, Anvari B. Acute Immune Response of Micro- and Nanosized Erythrocyte-Derived Optical Particles in Healthy Mice. Mol Pharm. 2020 10 05; 17(10):3900-3914.
-
Sun T, Dasgupta A, Zhao Z, Nurunnabi M, Mitragotri S. Physical triggering strategies for drug delivery. Adv Drug Deliv Rev. 2020; 158:36-62.
-
Cioloboc D, Kurtz DM. Targeted cancer cell delivery of arsenate as a reductively activated prodrug. J Biol Inorg Chem. 2020 05; 25(3):441-449.